Vanguard Group’s ENDRA Life Sciences NDRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-39,812
| Closed | -$3.87K | – | 4368 |
|
|
2024
Q2 | $3.87K | Hold |
39,812
| – | – | ﹤0.01% | 4408 |
|
|
2024
Q1 | $23.1K | Hold |
39,812
| – | – | ﹤0.01% | 4381 |
|
|
2023
Q4 | $84.4K | Buy |
39,812
+873
| +2% | +$1.85K | ﹤0.01% | 4319 |
|
|
2023
Q3 | $43.2K | Buy |
38,939
+12,388
| +47% | +$13.8K | ﹤0.01% | 4424 |
|
|
2023
Q2 | $37.2K | Sell |
26,551
-23,332
| -47% | -$32.7K | ﹤0.01% | 4488 |
|
|
2023
Q1 | $114K | Buy |
49,883
+2
| +0% | +$5 | ﹤0.01% | 4393 |
|
|
2022
Q4 | $203K | Sell |
49,881
-946,941
| -95% | -$3.85M | ﹤0.01% | 4309 |
|
|
2022
Q3 | $305K | Sell |
996,822
-174,225
| -15% | -$53.3K | ﹤0.01% | 4342 |
|
|
2022
Q2 | $273K | Sell |
1,171,047
-36,765
| -3% | -$8.57K | ﹤0.01% | 4423 |
|
|
2022
Q1 | $471K | Sell |
1,207,812
-503,959
| -29% | -$197K | ﹤0.01% | 4412 |
|
|
2021
Q4 | $1.18M | Sell |
1,711,771
-2,057
| -0.1% | -$1.42K | ﹤0.01% | 4217 |
|
|
2021
Q3 | $2.97M | Buy |
1,713,828
+4,728
| +0.3% | +$8.18K | ﹤0.01% | 3919 |
|
|
2021
Q2 | $3.73M | Buy |
1,709,100
+128,711
| +8% | +$281K | ﹤0.01% | 3742 |
|
|
2021
Q1 | $4.11M | Buy |
1,580,389
+1,482,489
| +1,514% | +$3.85M | ﹤0.01% | 3628 |
|
|
2020
Q4 | $73K | Hold |
97,900
| – | – | ﹤0.01% | 4165 |
|
|
2020
Q3 | $72K | Hold |
97,900
| – | – | ﹤0.01% | 4044 |
|
|
2020
Q2 | $94K | Hold |
97,900
| – | – | ﹤0.01% | 3986 |
|
|
2020
Q1 | $71K | Hold |
97,900
| – | – | ﹤0.01% | 3979 |
|
|
2019
Q4 | $164K | Sell |
97,900
-31,560
| -24% | -$52.9K | ﹤0.01% | 3965 |
|
|
2019
Q3 | $137K | Sell |
129,460
-80,748
| -38% | -$85.5K | ﹤0.01% | 3998 |
|
|
2019
Q2 | $359K | Sell |
210,208
-18,149
| -8% | -$31K | ﹤0.01% | 3879 |
|
|
2019
Q1 | $379K | Buy |
228,357
+15,781
| +7% | +$26.2K | ﹤0.01% | 3823 |
|
|
2018
Q4 | $319K | Buy |
+212,576
| New | +$319K | ﹤0.01% | 3819 |
|